Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin

Introduction | Browse | Search | Download
Mouse-over the above links for more information

Treatment details

LM ID Analyte Treatment Time(hrs) Sample ID Value Units
LMFA03010019 PGJ2 cPLA2i 1.0 BCD110605C28 0.274 pmol/ml medium
LMFA03010019 PGJ2 cPLA2i 1.0 BCD110605C30 0.303 pmol/ml medium
LMFA03010019 PGJ2 cPLA2i 1.0 BCD110605C29 0.251 pmol/ml medium
LMFA03010019 PGJ2 cPLA2i 20.0 BCD110605C64 0.261 pmol/ml medium
LMFA03010019 PGJ2 cPLA2i 20.0 BCD110605C66 0.186 pmol/ml medium
LMFA03010019 PGJ2 cPLA2i 20.0 BCD110605C65 0.194 pmol/ml medium
LMFA03010019 PGJ2 PLDi 1.0 BCD110605C16 0.169 pmol/ml medium
LMFA03010019 PGJ2 PLDi 1.0 BCD110605C17 0.175 pmol/ml medium
LMFA03010019 PGJ2 PLDi 1.0 BCD110605C18 0.193 pmol/ml medium
LMFA03010019 PGJ2 PLDi 20.0 BCD110605C54 0.276 pmol/ml medium
LMFA03010019 PGJ2 PLDi 20.0 BCD110605C52 0.281 pmol/ml medium
LMFA03010019 PGJ2 PLDi 20.0 BCD110605C53 0.248 pmol/ml medium
LMFA03010019 PGJ2 KDO+cPLA2i 1.0 BCD110605C32 0.334 pmol/ml medium
LMFA03010019 PGJ2 KDO+cPLA2i 1.0 BCD110605C31 0.311 pmol/ml medium
LMFA03010019 PGJ2 KDO+cPLA2i 1.0 BCD110605C33 0.332 pmol/ml medium
LMFA03010019 PGJ2 KDO+cPLA2i 20.0 BCD110605C68 0.516 pmol/ml medium
LMFA03010019 PGJ2 KDO+cPLA2i 20.0 BCD110605C69 0.601 pmol/ml medium
LMFA03010019 PGJ2 KDO+cPLA2i 20.0 BCD110605C67 0.551 pmol/ml medium
LMFA03010019 PGJ2 KDO+PLDi 1.0 BCD110605C19 0.181 pmol/ml medium
LMFA03010019 PGJ2 KDO+PLDi 1.0 BCD110605C20 0.179 pmol/ml medium
LMFA03010019 PGJ2 KDO+PLDi 1.0 BCD110605C21 0.203 pmol/ml medium
LMFA03010019 PGJ2 KDO+PLDi 20.0 BCD110605C56 0.9 pmol/ml medium
LMFA03010019 PGJ2 KDO+PLDi 20.0 BCD110605C57 0.841 pmol/ml medium
LMFA03010019 PGJ2 KDO+PLDi 20.0 BCD110605C55 0.665 pmol/ml medium
LMFA03010019 PGJ2 KDO+ATP+cPLA2i 1.0 BCD110605C37 0.24 pmol/ml medium
LMFA03010019 PGJ2 KDO+ATP+cPLA2i 1.0 BCD110605C38 0.28 pmol/ml medium
LMFA03010019 PGJ2 KDO+ATP+cPLA2i 1.0 BCD110605C39 0.24 pmol/ml medium
LMFA03010019 PGJ2 KDO+ATP+cPLA2i 20.0 BCD110605C74 0.882 pmol/ml medium
LMFA03010019 PGJ2 KDO+ATP+cPLA2i 20.0 BCD110605C75 0.89 pmol/ml medium
LMFA03010019 PGJ2 KDO+ATP+cPLA2i 20.0 BCD110605C73 0.827 pmol/ml medium
LMFA03010019 PGJ2 KDO+ATP+PLDi 1.0 BCD110605C25 0.207 pmol/ml medium
LMFA03010019 PGJ2 KDO+ATP+PLDi 1.0 BCD110605C27 0.174 pmol/ml medium
LMFA03010019 PGJ2 KDO+ATP+PLDi 1.0 BCD110605C26 0.199 pmol/ml medium
LMFA03010019 PGJ2 KDO+ATP+PLDi 20.0 BCD110605C61 2.31 pmol/ml medium
LMFA03010019 PGJ2 KDO+ATP+PLDi 20.0 BCD110605C62 2.49 pmol/ml medium
LMFA03010019 PGJ2 KDO+ATP+PLDi 20.0 BCD110605C63 2.35 pmol/ml medium
LMFA03010019 PGJ2 KDO + ATP 1.0 BCD110605C15 0.161 pmol/ml medium
LMFA03010019 PGJ2 KDO + ATP 1.0 BCD110605C14 0.175 pmol/ml medium
LMFA03010019 PGJ2 KDO + ATP 1.0 BCD110605C13 0.141 pmol/ml medium
LMFA03010019 PGJ2 KDO + ATP 20.0 BCD110605C49 2.79 pmol/ml medium
LMFA03010019 PGJ2 KDO + ATP 20.0 BCD110605C50 2.95 pmol/ml medium
LMFA03010019 PGJ2 KDO + ATP 20.0 BCD110605C51 2.78 pmol/ml medium
LMFA03010019 PGJ2 KDO 1.0 BCD110605C08 0.155 pmol/ml medium
LMFA03010019 PGJ2 KDO 1.0 BCD110605C07 0.196 pmol/ml medium
LMFA03010019 PGJ2 KDO 1.0 BCD110605C09 0.163 pmol/ml medium
LMFA03010019 PGJ2 KDO 20.0 BCD110605C45 0.657 pmol/ml medium
LMFA03010019 PGJ2 KDO 20.0 BCD110605C44 0.749 pmol/ml medium
LMFA03010019 PGJ2 KDO 20.0 BCD110605C43 0.76 pmol/ml medium
LMFA03010019 PGJ2 C 0.0 BCD110605C03 0.195 pmol/ml medium
LMFA03010019 PGJ2 C 0.0 BCD110605C01 0.155 pmol/ml medium